Pancreatic cancer: Advances and challenges

Halbrook, Christopher J., Lyssiotis, Costas A., Pasca di Magliano, Marina, Maitra, Anirban·2023·Cell
DOI 10.1016/j.cell.2023.02.014

Cited by (999)

Items 301–400 of 999

  1. ASPP2 Is Phosphorylated by CDK1 during Mitosis and Required for Pancreatic Cancer Cell Proliferation
    Yi Xiao, Yuanhong Chen, Jianan Chen, Jixin Dong · 2023 · Cancers
  2. Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer
    Paola Di Carlo, Nicola Serra, Teresa Fasciana, Anna Giammanco, Francesco D’Arpa, Teresa Rea, Mariasanta Napolitano, Alessandro Lucchesi, Antonio Cascio, Consolato Maria Sergi · 2024 · PLoS ONE
  3. AHNAK2 Regulates NF-κB/MMP-9 Signaling to Promote Pancreatic Cancer Progression
    Nana Tang, Rong-bo Xu, Bo Jiang, Hailing Zhang, Xiao-song Wang, Dan-dan Chen, Ji-Jun Zhu · 2024 · Biochemical Genetics
  4. P-move: a randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy
    Nico De Lazzari, Miriam Götte, Stefan Kasper, Eileen Meier, Martin Schüler, Michael Pogorzelski, Jens Thomas Siveke, Mitra Tewes · 2024 · Supportive Care in Cancer
  5. Recent advances in the treatment of pancreatic cancer
    Yongsu Ma, Fusheng Zhang, Yinmo Yang · 2024 · Holistic Integrative Oncology
  6. Cetylpyridinium chloride triggers paraptosis to suppress pancreatic tumor growth via the ERN1-MAP3K5-p38 pathway
    Hu Tang, Fangquan Chen, Wanli Gao, Xiutao Cai, Zhi Lin, Rui Kang, Daolin Tang, Jiao Liu · 2024 · iScience
  7. Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes
    Siyi Zou, Lei Zhang, Cen Jiang, Fanlu Li, Ying Yang, Xiaxing Deng, Jiao Zhang, Hao Chen, Lingxi Jiang, Xueyan Cheng et al. · 2024 · Cancer Letters
  8. MicroRNAs: emerging biomarkers and therapeutic targets in pancreatic cancer
    Jiaqian Yuan, Kaiqi Yan, Yong Guo, Yan Li · 2024 · Frontiers in Molecular Biosciences
  9. The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma
    Ricardo Blázquez‐Encinas, Emilia Alors‐Pérez, María Trinidad Moreno-Montilla, Víctor García‐Vioque, Marina Sánchez‐Frías, Andrea Mafficini, Juan Luis Lopez-Canovas, Corinne Bousquet, Manuel David Gahete, Rita Teresa Lawlor et al. · 2024 · Cancer Gene Therapy
  10. Sialyl-Tn glycan epitope as a target for pancreatic cancer therapies
    Rafaela Abrantes, Joanne Lopes, Daniel Lopes, Joana Gomes, Sónia A. Melo, Celso Albuquerque Reis · 2024 · Frontiers in Oncology
  11. Oncolytic vaccinia virus armed with 4–1BBL elicits potent and safe antitumor immunity and enhances the therapeutic efficiency of PD-1/PD-L1 blockade in a pancreatic cancer model
    Yushi Ju, Feiyu Dai, Yirong Wang, Zhenyu Ye, Yang Li, Songguang Ju, Yan Ge, Wei Chen · 2024 · Translational Oncology
  12. BNIP3+ fibroblasts associated with hypoxia and inflammation predict prognosis and immunotherapy response in pancreatic ductal adenocarcinoma
    Bo Gao, Guohua Hu, Boshi Sun, Wenqiang Li, Hao Yang · 2024 · Journal of Translational Medicine
  13. Gene expression dynamics in fibroblasts during early-stage murine pancreatic carcinogenesis
    Nupur Ohri, Johanna Häußler, Nino Javakhishvili, David Vieweg, Anais Aurelia Zourelidis, Bogusz Trojanowicz, Monika Hämmerle, Iréne Esposito, Markus Glaß, Yoshiaki Sunami et al. · 2024 · iScience
  14. Distinct response to IL-1β blockade in liver- and lung-specific metastasis mouse models of pancreatic cancer with heterogeneous tumor microenvironments
    Sophia Y. Chen, Heng‐Chung Kung, Birginia Espinoza, India Washington, Kai Chen, Kaiyi Mu, Haley Zlomke, Michael Loycano, Rulin Wang, William R. Burns et al. · 2025 · Experimental Hematology and Oncology
  15. Systematic review and meta-analysis: diagnostic accuracy of exosomes in pancreatic cancer
    Xinyi Xu, Chunyue Long, Meng Li, Chen‐Yang Shen, Qiuwen Ye, Yong Li, Hongyang Li, Xia Cao, Jun Ma · 2025 · World Journal of Surgical Oncology
  16. Salivary Extracellular Vesicles in Detection of Cancers Other than Head and Neck: A Systematic Review
    Wojciech Owecki, Karolina Wojtowicz, Kacper Nijakowski · 2025 · Cells
  17. The potential application of stroma modulation in targeting tumor cells: Focus on pancreatic cancer and breast cancer models
    Giuseppina Roscigno, S. Jacobs, Belén Toledo, Roberto Borea, Gianluca Russo, Francesco Pepe, María José Serrano, Viola Calabrò, Giancarlo Troncone, Roberto Giovannoni et al. · 2025 · Seminars in Cancer Biology
  18. A Self‐Reinforcing Metabolic Nanojammer for Activating Cascade‐Augmented Cuproptosis‐Driven Immunotherapy
    Yu Zhang, Yushu Dong, Shuiling Chen, Ming Li, Xia Liu, Jianwen Hou, Shaobing Zhou · 2025 · Advanced Functional Materials
  19. Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activation
    Zhe Zhang, Qitai Chen, Rujia Zheng, Zhenduo Shao, Xiaobao Wei, Xuanhao Gu, Yi Zang, Xi-shan Yang, Jiangchao Wu, Mengyao Dai et al. · 2025 · Journal of Controlled Release
  20. Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabine/Nab-Paclitaxel
    Qiuxia Yang, Yize Mao, Yulong Han, Kailai Li, Wanming Hu, Jianyao Zhou, Xuejun Gong, Shuxiang Huang, Rong Zhang, Lizhi Liu et al. · 2025 · Research
  21. Repurposing Artemisinin-Based Drugs from Antimalarial to Pan-Therapeutic: Pharmacological Promise and Therapeutic Challenges
    Di Wu, Hong Zeng, Jiachen Tan, Qianqian Xu, Faheem Ahmed Khan, Nuruliarizki Shinta Pandupuspitasari, Shengqiang Yang, Chunjie Huang · 2025 · Drug Design Development and Therapy
  22. Oncolytic viruses: A novel therapeutic approach for pancreatic cancer
    Mariana Esteves, Ana Miguel Matos, Maria Teresa Cruz · 2025 · Molecular Therapy Oncology
  23. Advancing β-Glucan-Based Immunomodulation and Nanotherapeutic Strategies for Cancer Biotherapy
    Neelakanta Sarvashiva Kiran, Darshini Subramaniam, Chandrashekar Yashaswini, Ankita Chatterjee, Bhupendra Gopalbhai Prajapati, Omar Awad Alsaidan, Sami Ibrahim Alzarea, Sankha Bhattacharya · 2025 · Cancer Biotherapy and Radiopharmaceuticals
  24. In situ multi-modal characterization of pancreatic cancer reveals tumor cell identity as a defining factor of the surrounding microenvironment
    Anna Lyubetskaya, Brian A. Rabe, Andrew J. Kavran, Yulong Bai, Andrew Fisher, Alba Font‐Tello, Anne C. Lewin, Hannah A. Pliner, Yunfan Fan, Lauren Giampapa et al. · 2026 · Cell Reports
  25. KRAS Inhibition in Pancreatic Ductal Adenocarcinoma
    Roshini Pradeep, Nooredeen Jamal Isbeih, Freya F. Abraham, Ehsan Noori, Zachary Phillip Yeung, Madappa N. Kundranda · 2026 · Journal of Clinical Medicine
  26. Preclinical Synergistic Combination Therapy of Lurbinectedin with Irinotecan and 5-Fluorouracil in Pancreatic Cancer
    Tej Tummala, Ashley Sanchez Sevilla Uruchurtu, Arielle De La Cruz, Kelsey E. Huntington, Andrew George, Nicholas R. Liguori, Leiqing Zhang, Lanlan Zhou, Abbas E. Abbas, Christopher G. Azzoli et al. · 2023 · Current Oncology
  27. A novel anti-galectin-9 immunotherapy limits the early progression of pancreatic neoplastic lesions in transgenic mice
    Alexandre Quilbé, Rami Mustapha, Bélinda Duchêne, Abhishek Kumar, Elisabeth Werkmeister, Emmanuelle Leteurtre, Olivier Moralès, Nicolas Jonckheere, Isabelle VAN SEUNINGEN, Nadira Delhem · 2023 · Frontiers in Immunology
  28. Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer
    Marco Erreni, Maria Rita Fumagalli, Damiano Zanini, Ermes Candiello, Giorgia Tiberi, Raffaella Parente, Raffaella D’Anna, Elena Illica Magrini, Federica Marchesi, Paola Cappello et al. · 2024 · International Journal of Molecular Sciences
  29. Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in pancreatic cancer
    Juanjuan Ye, Futoshi Suizu, Keiko Yamakawa, Yuri Mukai, Hiroyuki Yoneyama, Jiro Kondo, Motohiko Kato, Akira Nishiyama, Naohisa Yahagi, Kyuichi Kadota · 2024 · Molecular Therapy Oncology
  30. CHES1 modulated tumorigenesis and senescence of pancreas cancer cells through repressing AKR1B10
    Demin Kong, Ying‐Ying Wu, Binghua Tong, Yonghui Liang, Fuyi Xu, Xiaodong Chi, Lei Ni, Geng Tian, Guilong Zhang, Zhaowei Xu · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  31. Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A/B
    Emre Basar, Henry Mead, Bennett O. V. Shum, Ingrid Rauter, Cihan Ay, Adriane Skaletz‐Rorowski, Norbert H. Brockmeyer · 2024 · Pharmaceutics
  32. The Emerging Scenario of Ferroptosis in Pancreatic Cancer Tumorigenesis and Treatment
    Hao Lyu, Jinghua Kong, Jiasi Chen, Rui Zhang, Shuai Xiao, Dong Sheng Guo, Qi Zhang, Xing‐Zhen Chen, Jingfeng Tang, Cefan Zhou · 2024 · International Journal of Molecular Sciences
  33. Revolutionizing pancreatic cancer treatment with CAR-T therapy
    Kirti Baghel, Sanjana Mehrotra, Vijay Kumar Prajapati · 2025 · Advances in protein chemistry and structural biology
  34. Circular RNA in Pancreatic Cancer: Biogenesis, Mechanism, Function and Clinical Application
    Hang Chen, Xianxing Wang, Shan Liu, Ziwei Tang, Fuming Xie, Jingyang Yin, Pijiang Sun, Huaizhi Wang · 2025 · International Journal of Medical Sciences
  35. New avenues for the treatment of immunotherapy-resistant pancreatic cancer
    Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, Samuel Luca Rocha Pinheiro, Mariana Santos Calmon, Gabriel Lima Correa Santos, Gabriel Reis Rocha, Fabrício Freire de Melo · 2024 · World Journal of Gastrointestinal Oncology
  36. Inhibition of Nogo-B reduces the progression of pancreatic cancer by regulation NF-κB/GLUT1 and SREBP1 pathways
    Tianxiang Wang, Min Zhang, Xinyu Gong, Wanjing Chen, Ying Peng, Chenzhong Liao, Hongmei Xu, Qingshan Li, Guodong Shen, Huirong Ren et al. · 2024 · iScience
  37. Minocycline and Photodynamic Priming Significantly Improve Chemotherapy Efficacy in Heterotypic Spheroids of Pancreatic Ductal Adenocarcinoma
    Shazia Bano, José Quílez-Alburquerque, Harrison James Roberts, Sumiao Pang, Huang‐Chiao Huang, Tayyaba G. Hasan · 2024 · Journal of Photochemistry and Photobiology B Biology
  38. Nucleic acid-responsive smart systems for controlled cargo delivery
    Akbar Hasanzadeh, Arefeh Ebadati, Sara Saeedi, Babak Kamali, Hamid Noori, Behnam Jamei, Michael Richard Hamblin, Yong Liu, Mahdi Karimi · 2024 · Biotechnology Advances
  39. Small-molecule inhibitors of glucose transporters
    Makoto Kawatani, Hiroyuki Osada · 2024 · Vitamins and hormones
  40. Natural products as inhibitors against pancreatic cancer cell proliferation and invasion: possible mechanisms
    Xiang Li · 2024 · American Journal of Cancer Research
  41. Alterations of the bile microbiome is associated with progression-free survival in pancreatic ductal adenocarcinoma patients
    Hang Jiang, Yitong Tian, Linwei Xu, Xing Chen, Yurun Huang, Jia Wu, Tingzhang Wang, Tingting Liu, Xitian Wu, Chao Ye et al. · 2024 · BMC Microbiology
  42. The complement C3a/C3aR pathway is associated with treatment resistance to gemcitabine-based neoadjuvant therapy in pancreatic cancer
    Saimeng Shi, Long‐Yun Ye, Kaizhou Jin, Xianjun Yu, Duancheng Guo, Weiding Wu · 2024 · Computational and Structural Biotechnology Journal
  43. Proteomic Characterization of Urinary Exosomes with Pancreatic Cancer by Phosphatidylserine Imprinted Polymer Enrichment and Mass Spectrometry Analysis
    Xianhui Cheng, Wenjing Yu, Yuanyuan Liu, Shengnan Jia, Dongxue Wang, Lianghai Hu · 2024 · Journal of Proteome Research
  44. Combating PDAC Drug Resistance: The Role of Ref-1 Inhibitors in Accelerating Progress in Pancreatic Cancer Research
    Eyram K. Kpenu, Mark R. Kelley · 2024 · Journal of Cellular Signaling
  45. Depicting the cellular complexity of pancreatic adenocarcinoma by Imaging Mass Cytometry: focus on cancer-associated fibroblasts
    Marco Erreni, Maria Rita Fumagalli, Raffaella D’Anna, Mauro Sollai, Silvia Bozzarelli, Gennaro Nappo, Damiano Zanini, Raffaella Parente, Cecília Garlanda, Lorenza Rimassa et al. · 2024 · Frontiers in Immunology
  46. Oncogenic KRAS Promotes Ferroptosis in Pancreatic Cancer Through Regulation of the Fosl1-Tfrc Axis
    Huijia Zhao, Qi Huang, Yingao Liu, Wenming Wu · 2024 · Pancreas
  47. Hydrogel models of pancreatic adenocarcinoma to study cell mechanosensing
    M Walker, JP Morton · 2024 · Biophysical Reviews
  48. Accurate Diagnosis of Pancreatic Ductal Adenocarcinoma by Detection of miRNA‐196a Biomarker in Exosome Using Solution‐Gated Graphene Transistor with Antifouling Design
    Peng Song, Junqi Dong, Tingting Yu, Zexun Pan, Ziwen Chen, Ruixue Wang, Ming Wang, Liang Zhao, Xianbao Wang, Jinhua Li · 2025 · Advanced Healthcare Materials
  49. Photodynamic Priming with Red Light Triggers Adaptive Immune Responses in a Pancreatic Cancer Mouse Model
    Pushpamali De Silva, Mohammad Ahsan Saad, Joseph W. R. Swain, Zhiming Mai, Madeline D. Kidd, Joanna Joeun Choe, Assiris P. Camargo, Sanjay Anand, Vinay Chandrasekhara, Brian W. Pogue et al. · 2024 · Journal of Photochemistry and Photobiology B Biology
  50. Serum proteomics reveals survival-associated biomarkers in pancreatic cancer patients treated with chemoimmunotherapy
    Marco Tognetti, Lopamudra Chatterjee, Nigel Beaton, Kamil Skłodowski, Roland Bruderer, Lukas Reiter, Christoph B. Messner · 2025 · iScience
  51. PPY‐Induced iCAFs Cultivate an Immunosuppressive Microenvironment in Pancreatic Cancer
    Mengdie Cao, Wang Peng, Bin Cheng, Ronghua Wang, Wei Chen, Luyao Liu, Hai Huang, Shiru Chen, Haochen Cui, Jingwen Liang et al. · 2025 · Advanced Science
  52. Targeting MYOF suppresses pancreatic ductal adenocarcinoma progression by inhibiting ILF3-LCN2 signaling through disrupting OTUB1-mediated deubiquitination of ILF3
    Zhihui Li, Jianlei Zhang, Jiang Yin, Wen Ma, Hongfan Liao, Lv Ling, Qingfeng Zou, Yabing Cao, Ying Song, Guopei Zheng et al. · 2025 · Redox Biology
  53. Mesoporous Magnetic Graphene for Serum Metabolic Profiling in Non-Invasive Early Detection and Diagnosis of Pancreatic Ductal Adenocarcinoma
    Jia Qi, Caiyun Fang, Chunhui Deng, Fangying Shi, Qunyan Yao · 2025 · ACS Applied Materials & Interfaces
  54. Vessel‐Like Microtunnels with Biomimetic Octopus Tentacles for Seizing and Detecting Exosomes to Diagnose Pancreatic Cancer
    Lili Xu, Ming Wang, Yi‐Ke Wang, Yi‐Jing Chen, Yu‐Xin Zhang, Yan‐Qiu Zhang, Shi‐Bo Cheng, Min Xie, Wei‐Hua Huang · 2025 · Small
  55. Nuclear localization of YAP in pancreatic cancer: More players besides Hippo pathway
    Yiping Xie, Cheng Yong Qin, Xiangyu Zhang, Zeru Li, Bangbo Zhao, Tianyu Li, Yutong Zhao, Yutong Yan, Haoyu Shi, Lirui Huang et al. · 2025 · Cancer Letters
  56. Computational theranostics strategy for pancreatic ductal adenocarcinoma
    Pradnya Kamble, Tanmaykumar Varma, Rajender Kumar, Prabha Garg · 2025 · Molecular Diversity
  57. AI-Powered Deep Visual Proteomics Reveals Critical Molecular Transitions in Pancreatic Cancer Precursors
    Jimin Min, Lisa Schweizer, Gijs Zonderland, Benson Chellakkan Selvanesan, Julie H. Thomsen, Lukas Oldenburg, Seong-Woo Bae, Bongjun Kim, Sharia D. Hernandez, Gabriela Jez et al. · 2026 · Cancer Discovery
  58. SenExo‐cCCT2 Reprograms Senescence Response and Anti‐Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Ductal Adenocarcinoma
    Shun‐Cang Zhu, Yinhao Chen, Hongyi Lin, Jinpeng Lu, Yu Pan, Ge Li, Yongding Wu, Haoxiang Zhang, Xiaoxiao Huang, Yi‐Ting Chen et al. · 2025 · Advanced Science
  59. Mitochondria-centric lipid metabolism and inter-organelle crosstalk in pancreatic Cancer: Unveiling novel therapies
    Runxian Wang, Changhao Gao, Zhiyao Fan, Qingdi Qin, Hanxiang Zhan · 2025 · Cancer Letters
  60. Beyond the stomach: the association between Helicobacter pylori and the spectrum of digestive cancers
    Xin He, Chi Zhu, Chan Zhu, Xing Zhang, Dongsheng Chen, Qingping Wang · 2025 · Frontiers in Cellular and Infection Microbiology
  61. Tumor microenvironment subtyping in pancreatic ductal adenocarcinoma: New avenues for personalized therapeutic strategies
    Dharini Srinivasan, Johann Gout, Alexander Kleger, Élodie Roger · 2025 · Advanced Drug Delivery Reviews
  62. The Interplay of Aging and Cancer: Mechanisms, Implications, and Therapeutic Strategies
    Liangce Wang, Yaru Luo, Xin Chen, Yuan Wang, Yan Zhang · 2025 · MedComm – Oncology
  63. Non-Invasive Pancreas Ablation Using Histotripsy: Pre-clinical Safety Study in an In Vivo Porcine Model
    Jessica Gannon, Tamalika Paul, Khan Mohammad Imran, Michael Richard Edwards, Timothy J. Ziemlewicz, Brie Trusiano, Tyler M. Moore, Cora Youngs, Manali Powar, Amber Keith et al. · 2025 · Ultrasound in Medicine & Biology
  64. Probiotic-inspired hybrid nanovesicles for enhancing immune checkpoint therapy efficiency via tumor immune microenvironment modulation
    Fang Wang, Jinghao Fan, Wenping Pan, Mingkang Liu, Jiaxin Wang, Xue Wei, Yiwen Xian, Shiyi Chen, Chunhong Cui, Yongmiao Chen et al. · 2025 · Bioactive Materials
  65. Digital and AI-assisted multimodal supportive care, combining physical activity, nutrition, and pain management during chemotherapy for advanced pancreatic cancer patients: study protocol of the European multicenter randomized controlled trial of the RELEVIUM project
    Barlo Hillen, Gabrielle Oestreicher, Lisa Schwab, Kira Enders, Perikles D. Simon, Anneli Elme, Irit Ben‐Aharon, T.G. Goshen - Lago, Cindy Neuzillet, Francesco Sclafani et al. · 2025 · BMC Cancer
  66. m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis
    Zhen Tan, Jianhui Yang, Yueyue Chen, Heng Zhu, Xiaomeng Liu, Xu He, Qingcai Meng, Mingming Xiao, Rong Tang, Zeyin Rong et al. · 2025 · Cell Death and Disease
  67. Immunosuppressive tumor microenvironment shape pancreatic cancer unresponsive to current immunotherapies
    Zong-Yang Li, Si-Yu Peng, Fei-Long Li, Hong-Qiao Cai · 2026 · World Journal of Clinical Oncology
  68. Tumor cell death by ferroptosis contributes to an immunosuppressive tumor microenvironment in syngeneic murine models of cancer
    Nneka E. Mbah, Damien Sutton, Hanna S. Hong, Rashi Singhal, Rosa Elena Menjivar, Matthew D. Perricone, Heather Giza, Peter Sajjakulnukit, Amy L. Myers, Zeribe C. Nwosu et al. · 2026 · Cancer & Metabolism
  69. An unexpected pathway to polyamines in pancreatic cancer
    Dominik Awad, Costas Andreas Lyssiotis · 2023 · Molecular Cell
  70. Top advances of the year: Pancreatic cancer
    Emilie A. K. Warren, Gregory B. Lesinski, Shishir Kumar Maithel · 2023 · Cancer
  71. TGFβ and Hippo Signaling Pathways Coordinate to Promote Acinar to Ductal Metaplasia in Human Pancreas
    MICHAEL J. NIPPER, Yi Xu, Jun Liu, Xue Yin, Zhijie Liu, Zhengqing Ye, Jianmin Zhang, Yidong Chen, Pei Wang · 2024 · Cells
  72. Prognostic value of venous thromboembolism in patients with advanced pancreatic cancer: a systematic review and meta-analysis
    Kaifeng Su, Ruifeng Duan, Yang Wu · 2024 · Frontiers in Oncology
  73. Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8 + T cell function and its impact against pancreatic ductal adenocarcinoma
    Wei Wei, Linqing Tian, Xiaoyan Zheng, Lei Zhong, Yuan Chen, Hui Dong, Guibing Zhang, Shibing Wang, Xiangmin Tong · 2024 · OncoImmunology
  74. Meaningful nomograms based on systemic immune inflammation index predicted survival in metastatic pancreatic cancer patients receiving chemotherapy
    Yanan Sun, Jiahe Hu, Rongfang Wang, Xinlian Du, Xiaoling Zhang, E Jiaoting, Shaoyue Zheng, Yuxin Zhou, Ruishu Mou, Xuedong Li et al. · 2024 · Cancer Medicine
  75. Exploring Disparities in Pancreatic Ductal Adenocarcinoma Outcomes among Asian and Pacific Islander Subgroups
    Christopher Wu, Chandler McLeod, Zhixing Song, Herbert Chen, John Bart Rose, Smita Bhatia, Andrea Gillis · 2024 · Cancer Research Communications
  76. Personalized PDAC chip with functional endothelial barrier for tumour biomarker detection: A platform for precision medicine applications
    Karīna Goluba, Vadims Parfejevs, Evita Rostoka, Kaspars Jēkabsons, Ilze Blāķe, Anastasija Neimane, Annija Anete Ule, Roberts Rimša, Reinis Vangravs, Andrejs Pčolkins et al. · 2024 · Materials Today Bio
  77. Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies
    Seiichiro Takao, Hiroshi Fukushima, Aki Furusawa, Takuya Kato, Shuhei Okuyama, Makoto Kano, Hiroshi Yamamoto, Motofumi Suzuki, Miyu Kano, Peter L. Choyke et al. · 2025 · Cancer Immunology Immunotherapy
  78. Radiation therapy for locally advanced pancreatic adenocarcinoma: a therapeutic option which should not be forgotten. Letter to the Editor regarding: “Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up” by Huguet et al.
    F. Huguet, Christelle Bouchart, Anna M E Bruynzeel, M. Hawkins, S. Mukherjee, Joost J.M.E. Nuyttens, Olivier Riou, Marta Scorsetti, Eva Versteijne, Mauro Loi et al. · 2024 · Annals of Oncology
  79. Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models
    Serala, Karabo, Bai, Jinming, Prince, Sharon · 2024 · Journal of Cellular and Molecular Medicine
  80. BCL6 overexpression in CD4+ T cells induces Tfh-like transdifferentiation and enhances antitumor efficiency of CAR-T therapy in pancreatic cancer
    Xuan Lin, Zhengjie Dai, Yesiboli Tasiheng, Rulin Zhang, Ruijie Wang, Jia Dong, Yusheng Chen, Mingjian Ma, Xuan Zou, Yu Yan et al. · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  81. Prognostic Value of Performance Status, Albumin, and CRP in Last-Line Chemotherapy for Pancreatic vs. Other Gastrointestinal Cancers—Simple Tools Matter
    Arne Westgaard, Aleksandra Pirnat, Marianne Jensen Hjermstad, Nina Aass, Stein Kaasa, Olav Faisal Dajani · 2024 · Current Oncology
  82. Construction of a combined prognostic model for pancreatic ductal adenocarcinoma based on deep learning and digital pathology images
    Kaixin Hu, Chenyang Bian, Jiayin Yu, Dawei Jiang, Zhangjun Chen, Fengqing Zhao, Huangbao Li · 2024 · BMC Gastroenterology
  83. CAFomics: convergence to translation for precision stroma approaches
    Ian C. McCabe, Xianlu L. Peng, Joseph F. Kearney, Jen Jen Yeh · 2024 · Carcinogenesis
  84. YAP1 Overexpression Enhances the Aerobic Glycolysis Process via Suppression of EGLN2 in Pancreatic Ductal Adenocarcinoma
    Pengfei Hu, Ruohan Dou, Zihao Qi, Guanya Liu, Yuantao Su · 2024 · The Journal of Gene Medicine
  85. Identification of SMAD4-mutated pancreatic ductal adenocarcinoma using preoperative contrast-enhanced MRI and clinical characteristics
    Zhina Li, Cheng Wang, Jianbo Li, Xingxing Wang, Xiang Li, Tianzhu Yu, Jianjun Zhou, Xiaolin Wang, Mengsu Zeng, Haitao Sun · 2024 · BMC Medical Imaging
  86. Exploiting synthetic lethality in PDAC with antibody drug conjugates and ATR inhibition
    Tao Li, Xianqiang Yu, Xinyao Wan, Jing Liu, Jie Zheng, Ziyu Sun, Yi Zhao, Jiakang Chen, Hongli Chen, Yifeng Yang et al. · 2025 · European Journal of Medicinal Chemistry
  87. Enhancing KRAS G12D inhibitor sensitivity in pancreatic cancer through SHP2/PI3K pathway
    Man-Wei Hao, Tian‐Xing Zhang, Dan Feng Dong, Xin Min ZHOU, Haicheng Gao · 2025 · Medical Oncology
  88. Multifunctional nanoplatform for tumor chemodynamic and self-amplified photodynamic cascade therapy
    Xingyu Luo, Haifeng Qi, Manqi Yan, Tong Xu, Ting Wu, Yin Ding, Wei Han · 2025 · Journal of Advanced Research
  89. Combining genetic and non-genetic factors to predict the risk of pancreatic cancer in patients with new-onset diabetes mellitus
    Yu Zhou, Zhuo Kui Wu, Liangtang Zeng, Rufu Chen · 2025 · BMC Medicine
  90. Advancements in molecular imaging for the diagnosis and treatment of pancreatic ductal adenocarcinoma
    Xun Hu, Zihua Wang, Yuting Zhu, Zhangfu Li, Hao Yan, Li Zhao, Qian Wang · 2025 · Nanoscale Advances
  91. Research prospects and AI-driven strategies for metal–organic framework-hydrogel composite materials in cancer treatment
    Zijun Zhang, Yuelin Zhang, Taiwei Liang, Jiajia Zhang, Weidong Liu, Ying H. Pan, Jianqiang Liu, Xiaoxiu Li · 2025 · RSC Medicinal Chemistry
  92. A thermosensitive hydrogel with synergistic stromal targeting and antitumor immunity modulation for pancreatic cancer immunotherapy
    Guozhi Zhao, Fan Guo, Wenhui Yan, Ying Qu, Chongzheng Yan, Huaiyou Lv, Genju Li, Jianxiong Zhao, Hanmiao Xie, Yizhe Li et al. · 2025 · Materials Today Bio
  93. Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinoma
    Greyson W. G. Biegert, Amanda Rosewell Shaw, Daisuke Morita, Caroline Porter, Ryu Matsumoto, Lisa Jatta, Noah Crooks, Mae Louise Woods, Qizhi Cathy Yao, Robin Parihar et al. · 2025 · Molecular Therapy Oncology
  94. Histamine H3 receptor: an emerging target for cancer therapy?
    Paolo Lauretta, Rocío Martínez Vivot, Agueda Velazco, Vanina A. Medina · 2025 · Inflammation Research
  95. M1 Macrophage-Derived Extracellular Vesicles Loaded with CX3CR1 siRNA for the Treatment of Pancreatic Cancer
    Miao Cheng, Guangzhao Huang, Yi Wen, Yixiao He, Peng Bai, Yan Wei, Longjiang Li, Chunjie Li, Ailin Wei, Jiaolin Wen · 2025 · ACS Applied Materials & Interfaces
  96. Navigating the complexities of pancreatic ductal adenocarcinoma: A review on therapeutic models and RAS inhibitors
    Sara Barrambana, Elena Zamorano-Domínguez, Vasiliki Liaki, Carmen E. Guerra · 2025 · Advanced Drug Delivery Reviews
  97. Nudibranchs as Sources of Marine Natural Products with Antitumor Activity: A Comprehensive Review
    Máximo Servillera, Mercedes Peña, Laura Cabeza, Héctor J. Pula, Jose Carlos Prados, Consolación Melguizo · 2025 · Marine Drugs
  98. UBE2C promotes pancreatic tumorigenesis by KRAS stabilization via APC/CCDH1-mediated WDR76 degradation
    Linchen Wang, Xiaoyu Chen, Ruirui Qu, Shengpeng Shao, Longyuan Gong, Tianqi Li, Shanghong Jiang, Yu‐Ying Lu, Ying Ma, Yi Ning Sun et al. · 2025 · Cancer Letters
  99. Label-free impedimetric biosensor based on lectin and polypyrrole film for the early detection of pancreatic cancer cells
    Brenda Marques de Cerqueira, Alberto Galdino da Silva Júnior, Karen Y.P.S. Avelino, Valécia de Cássia Mendonça da Costa, Moacyr Jesus Barreto de Melo Rêgo, Maíra Galdino da Rocha Pitta, César A.S. Andrade, Maria D.L. Oliveira · 2025 · Journal of Pharmaceutical and Biomedical Analysis
  100. Targeting TNK2/ACK1 reverses the immunosuppressive tumor microenvironment and synergizes with immunochemotherapy in pancreatic cancer
    Chao Wu, Weishuai Liu, Xiangting Hu, Yongjie Xie, Shengnan Li, Xinyue Liu, Zhaojun Sun, Xiaoling Li, Xin Yu, Yudong Yuan et al. · 2025 · Nature Communications